Yutaka Okawa

2.9k citations

46 papers · 1.9k indexed · h-index 18

Hematology top 2%
- Multiple Myeloma Research and Treatments 12
Oncology top 5%
- Peptidase Inhibition and Analysis 3
Molecular Biology top 10%
- Ubiquitin and proteasome pathways 9
- Glycosylation and Glycoproteins Research 5
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 3
Genetics top 10%
Cancer Research top 10%
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 5
Neurology
- CNS Lymphoma Diagnosis and Treatment 3

Co-authors: Noopur Raje Teru Hideshima Kenneth C. Anderson Hiroshi Ikeda Nikhil C. Munshi Dharminder Chauhan Paul G. Richardson Sonia Vallet
Cited by: Hematology Oncology Molecular Biology
Journals: Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)Blood (9 papers)
Partner nations: Japan United States Italy

In The Last Decade

Yutaka Okawa

44 papers receiving 1.8k citations

Peers

Countries citing papers authored by Yutaka Okawa

Since Specialization

Citations

This map shows the geographic impact of Yutaka Okawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Okawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Okawa more than expected).

Fields of papers citing papers by Yutaka Okawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Okawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Okawa. The network helps show where Yutaka Okawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yutaka Okawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yutaka Okawa Line = papers co-authored together Yutaka Okawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	3D niche microarrays for systems-level analyses of cell fate Nature Communications ·Adrian Ranga,Samy Gobaa,Yutaka Okawa,Katarzyna A. Mosiewicz,Alessandro Negro,Matthias P. Lütolf	2014	184
2	Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines Oncology Reports ·Yasuhiro Arakawa,Koji Ozaki,Yutaka Okawa,Hisashi Yamada	2013	14
3	PI3K/p110δ is a novel therapeutic target in multiple myeloma Blood ·Hiroshi Ikeda,Teru Hideshima,Mariateresa Fulciniti,Giulia Perrone,Naoya Miura,Hiroshi Yasui,Yutaka Okawa,Tanyel Kiziltepe,Loredana Santo,Sonia Vallet,Diana Cristea,Elisabetta Calabrese,Güllü Görgün,Noopur Raje,Paul G. Richardson,Nikhil C. Munshi,Brian J. Lannutti,Kamal D. Puri,Neill A. Giese,Kenneth C. Anderson	2010	156
4	AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition Oncogene ·Loredana Santo,Sonia Vallet,Teru Hideshima,Diana Cirstea,Hiroshi Ikeda,Samantha Pozzi,Kishan Patel,Yutaka Okawa,Güllü Görgün,Giulia Perrone,Elisabetta Calabrese,Murray Yule,Matthew Squires,Marco Ladetto,Mario Boccadoro,Paul G. Richardson,Nikhil C. Munshi,K C Anderson,Noopur Raje	2010	114
5	The proteasome inhibitor bortezomib inhibits FGF‐2‐induced reduction of TAZ levels in osteoblast‐like cells European Journal Of Haematology ·Homare Eda,Katsuhiko Aoki,Soki Kato,Yutaka Okawa,Koji Takada,Takaaki Tanaka,Keishi Marumo,Kiyoshi Ohkawa	2010	11
6	Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma Leukemia ·Iris Breitkreutz,Marc S. Raab,Sonia Vallet,Teru Hideshima,Noopur Raje,Constantine S. Mitsiades,Dharminder Chauhan,Yutaka Okawa,Nikhil C. Munshi,Paul G. Richardson,Kenneth C. Anderson	2008	166
7	Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells British Journal of Haematology ·Teru Hideshima,Laurence Catley,Noopur Raje,Dharminder Chauhan,Klaus Podar,Constantine S. Mitsiades,Yu‐Tzu Tai,Sonia Vallet,Tanyel Kiziltepe,Enrique M. Ocio,Hiroshi Ikeda,Yutaka Okawa,Hiromasa Hideshima,Nikhil C. Munshi,Hiroshi Yasui,Paul G. Richardson,Kenneth C. Anderson	2007	82
8	Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway Leukemia ·Hiroshi Yasui,Teru Hideshima,Hiroshi Ikeda,Enrique M. Ocio,Tanyel Kiziltepe,Sonia Vallet,Yutaka Okawa,Paola Neri,Kumar Sukhdeo,Klaus Podar,Dharminder Chauhan,Paul G. Richardson,Noopur Raje,Daniel R. Carrasco,Kenneth C. Anderson	2007	21
9	Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells The International Journal of Biochemistry & Cell Biology ·Jiro Minami,Koji Takada,Katsuhiko Aoki,Yohta Shimada,Yutaka Okawa,Noriko Usui,Kiyoshi Ohkawa	2006	9
10	BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen‐activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth British Journal of Haematology ·Hiroshi Yasui,Teru Hideshima,Hiroshi Ikeda,Janice Jin,Enrique M. Ocio,Tanyel Kiziltepe,Yutaka Okawa,Sonia Vallet,Klaus Podar,Kenji Ishitsuka,Paul G. Richardson,Chris Pargellis,Neil Moss,Noopur Raje,Kenneth C. Anderson	2006	40
11	Long-Term Follow-up High-Dose Chemotherapy (Drug-Only Program) Followed by Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas Clinical Lymphoma ·Noriko Usui,Shingo Yano,Osamu Asai,Nobuaki Dobashi,Hiroshi Osawa,Yutaka Takei,Katsuki Sugiyama,Shinobu Takahara,Hiroko Otubo,Takeshi Saito,Yutaka Okawa,Takeshi Hagino,Ken Kaito,Masayuki Kobayashi	2005	5
12	Successful combination therapy with trastuzumab and paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer Breast Cancer ·Yutaka Okawa,Katsuki Sugiyama,Keisuke Aiba,Akio Hirano,Shinji Uno,Takeshi Hagino,Kazumi Kawase,Hisashi Shioya,Kazuhiko Yoshida,Masao Kobayashi,Noriko Usui,Tadashi Kobayashi	2004	4
13	Primary central nervus system lymphoma developing methotrexate pneumonitis due to high-dose treatment Chemotherapy ·Yutaka Takei,Noriko Usui,Takeshi Hagino,Yutaka Okawa,Katsuki Sugiyama,Shinji Uno,Nobuaki Dobashi,Masayuki Kobayashi	2003	1
14	Purification of N-terminally truncated histone H2A-monoubiquitin conjugates from leukemic cell nuclei: probable proteolytic products of ubiquitinated H2A The International Journal of Biochemistry & Cell Biology ·Yutaka Okawa,Koji Takada,Jiro Minami,Katsuhiko Aoki,Hirohiko Shibayama,Kiyoshi Ohkawa	2003	12
15	Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia International Journal of Hematology ·Noriko Usui,Nobuaki Dobashi,Osamu Asai,Shingo Yano,Yuichi Yahagi,Takeshi Saito,Yuko Yamaguchi,Kinuyo Kasama,Yutaka Okawa,Naohiro Sekiguchi,Yutaka Takei,Katsuki Sugiyama,Yoji Ogasawara,Hiroko Ohtsubo,Ken Kaito,Masayuki Kobayashi	2002	4
16	Isolation of ubiquitin‒E2 (ubiquitin-conjugating enzyme) complexes from erythroleukaemia cells using immunoaffinity techniques Biochemical Journal ·Koji Takada,Tae Hirakawa,Hideyoshi Yokosawa,Yutaka Okawa,Hideki Taguchi,Kiyoshi Ohkawa	2001	12
17	Purification and identification of monoubiquitin-phosphoglycerate mutase B complex from human colorectal cancer tissues International Journal of Cancer ·Teruyuki Usuba,Yoshio Ishibashi,Yutaka Okawa,Tae Hirakawa,Koji Takada,Kiyoshi Ohkawa	2001	30
18	Calpain inhibitor inhibits secretory granule maturation and secretion of GH Neuroreport ·Kiyoshi Ohkawa,Koji Takada,Tadashi Asakura,Yukio Hashizume,Yutaka Okawa,Ken-ichi Tashiro,Junko Ueda,Yoshitaka Itoh,Nozomu Hibi	2000	11
19	Study on Reuse of Returned Concrete Concrete Research and Technology ·Yutaka Okawa,Hironobu Yamamiya,Shinzo Nishibayashi	1997	1
20	Liver lipids of gonatid squid Berryteuthis magister: A rich source of alkyl glyceryl ethers. NIPPON SUISAN GAKKAISHI ·Kenji Hayashi,Yutaka Okawa,Ken‐ichi Kawasaki	1985	18

About Yutaka Okawa

Yutaka Okawa is a scholar working on Hematology, Oncology and Cancer Research, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Ubiquitin and proteasome pathways (9 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Mechanisms and Therapy (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer therapeutics and mechanisms (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (612 citations), Oncology (604 citations) and Molecular Biology (1.2k citations). Yutaka Okawa has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Noopur Raje, Teru Hideshima, Kenneth C. Anderson, Hiroshi Ikeda, Nikhil C. Munshi, Dharminder Chauhan, Paul G. Richardson, Sonia Vallet, Tanyel Kiziltepe and Constantine S. Mitsiades. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact